Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS

Maria C. Rodriguez-Barradas, Edward Stool, Daniel M. Musher, Joseph Gathe, Jane Goldstein, Robert R I Genta, Boris Yoffe

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Because cytomegalovirus (CMV) can be isolated from pulmonary secretions of human immunodeficiency virus (HIV)-infected patients without causing disease, its clinical significance as a cause of pneumonia in this patient population is frequently questioned. In a 22-month period, CMV pneumonia was diagnosed in 17 (8%) of 210 HIV-infected patients who underwent lung biopsy on the basis of microbiological and histologic criteria. The clinical presentations of these patients were nonspecific, including fever (100% of patients), shortness of breath (71%), cough (76%), and PaO2 of <75 mm Hg (88%). A high correlation in the degree of viral burden in lung biopsy specimens was demonstrated by histologic examination, immunohistochemical analysis, and in situ hybridization. No other pulmonary pathogens were identified for nine patients, whereas other possible causes of pneumonia were present in eight; 11 patients had evidence of extrapulmonary CMV disease at presentation. Most patients initially responded to specific anti- CMV therapy; the overall mean survival ± SD was 3.1 ± 2.5 months. CMV should be considered as a possible cause of pneumonia in patients with advanced AIDS especially if CMV infection is documented at other sites.

Original languageEnglish (US)
Pages (from-to)76-81
Number of pages6
JournalClinical Infectious Diseases
Volume23
Issue number1
StatePublished - 1996

Fingerprint

Cytomegalovirus
Pneumonia
Acquired Immunodeficiency Syndrome
Lung
HIV
Biopsy
Cytomegalovirus Infections
Viral Load
Cough
Dyspnea
In Situ Hybridization
Fever
Survival
Population

ASJC Scopus subject areas

  • Immunology

Cite this

Rodriguez-Barradas, M. C., Stool, E., Musher, D. M., Gathe, J., Goldstein, J., Genta, R. R. I., & Yoffe, B. (1996). Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clinical Infectious Diseases, 23(1), 76-81.

Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. / Rodriguez-Barradas, Maria C.; Stool, Edward; Musher, Daniel M.; Gathe, Joseph; Goldstein, Jane; Genta, Robert R I; Yoffe, Boris.

In: Clinical Infectious Diseases, Vol. 23, No. 1, 1996, p. 76-81.

Research output: Contribution to journalArticle

Rodriguez-Barradas, MC, Stool, E, Musher, DM, Gathe, J, Goldstein, J, Genta, RRI & Yoffe, B 1996, 'Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS', Clinical Infectious Diseases, vol. 23, no. 1, pp. 76-81.
Rodriguez-Barradas MC, Stool E, Musher DM, Gathe J, Goldstein J, Genta RRI et al. Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clinical Infectious Diseases. 1996;23(1):76-81.
Rodriguez-Barradas, Maria C. ; Stool, Edward ; Musher, Daniel M. ; Gathe, Joseph ; Goldstein, Jane ; Genta, Robert R I ; Yoffe, Boris. / Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. In: Clinical Infectious Diseases. 1996 ; Vol. 23, No. 1. pp. 76-81.
@article{a2a987f04e994cdbaae34c37e94c725d,
title = "Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS",
abstract = "Because cytomegalovirus (CMV) can be isolated from pulmonary secretions of human immunodeficiency virus (HIV)-infected patients without causing disease, its clinical significance as a cause of pneumonia in this patient population is frequently questioned. In a 22-month period, CMV pneumonia was diagnosed in 17 (8{\%}) of 210 HIV-infected patients who underwent lung biopsy on the basis of microbiological and histologic criteria. The clinical presentations of these patients were nonspecific, including fever (100{\%} of patients), shortness of breath (71{\%}), cough (76{\%}), and PaO2 of <75 mm Hg (88{\%}). A high correlation in the degree of viral burden in lung biopsy specimens was demonstrated by histologic examination, immunohistochemical analysis, and in situ hybridization. No other pulmonary pathogens were identified for nine patients, whereas other possible causes of pneumonia were present in eight; 11 patients had evidence of extrapulmonary CMV disease at presentation. Most patients initially responded to specific anti- CMV therapy; the overall mean survival ± SD was 3.1 ± 2.5 months. CMV should be considered as a possible cause of pneumonia in patients with advanced AIDS especially if CMV infection is documented at other sites.",
author = "Rodriguez-Barradas, {Maria C.} and Edward Stool and Musher, {Daniel M.} and Joseph Gathe and Jane Goldstein and Genta, {Robert R I} and Boris Yoffe",
year = "1996",
language = "English (US)",
volume = "23",
pages = "76--81",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS

AU - Rodriguez-Barradas, Maria C.

AU - Stool, Edward

AU - Musher, Daniel M.

AU - Gathe, Joseph

AU - Goldstein, Jane

AU - Genta, Robert R I

AU - Yoffe, Boris

PY - 1996

Y1 - 1996

N2 - Because cytomegalovirus (CMV) can be isolated from pulmonary secretions of human immunodeficiency virus (HIV)-infected patients without causing disease, its clinical significance as a cause of pneumonia in this patient population is frequently questioned. In a 22-month period, CMV pneumonia was diagnosed in 17 (8%) of 210 HIV-infected patients who underwent lung biopsy on the basis of microbiological and histologic criteria. The clinical presentations of these patients were nonspecific, including fever (100% of patients), shortness of breath (71%), cough (76%), and PaO2 of <75 mm Hg (88%). A high correlation in the degree of viral burden in lung biopsy specimens was demonstrated by histologic examination, immunohistochemical analysis, and in situ hybridization. No other pulmonary pathogens were identified for nine patients, whereas other possible causes of pneumonia were present in eight; 11 patients had evidence of extrapulmonary CMV disease at presentation. Most patients initially responded to specific anti- CMV therapy; the overall mean survival ± SD was 3.1 ± 2.5 months. CMV should be considered as a possible cause of pneumonia in patients with advanced AIDS especially if CMV infection is documented at other sites.

AB - Because cytomegalovirus (CMV) can be isolated from pulmonary secretions of human immunodeficiency virus (HIV)-infected patients without causing disease, its clinical significance as a cause of pneumonia in this patient population is frequently questioned. In a 22-month period, CMV pneumonia was diagnosed in 17 (8%) of 210 HIV-infected patients who underwent lung biopsy on the basis of microbiological and histologic criteria. The clinical presentations of these patients were nonspecific, including fever (100% of patients), shortness of breath (71%), cough (76%), and PaO2 of <75 mm Hg (88%). A high correlation in the degree of viral burden in lung biopsy specimens was demonstrated by histologic examination, immunohistochemical analysis, and in situ hybridization. No other pulmonary pathogens were identified for nine patients, whereas other possible causes of pneumonia were present in eight; 11 patients had evidence of extrapulmonary CMV disease at presentation. Most patients initially responded to specific anti- CMV therapy; the overall mean survival ± SD was 3.1 ± 2.5 months. CMV should be considered as a possible cause of pneumonia in patients with advanced AIDS especially if CMV infection is documented at other sites.

UR - http://www.scopus.com/inward/record.url?scp=0029835152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029835152&partnerID=8YFLogxK

M3 - Article

C2 - 8816133

AN - SCOPUS:0029835152

VL - 23

SP - 76

EP - 81

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -